Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of LM001 vs Gonal-F in Healthy Female Volunteers
NCT03535103Phase 1Unknown
- Sponsor
- Alphamab Oncology
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of LM-001 in infertility (2 arms), sponsored by Alphamab Oncology. Primary endpoints: Maximum observed serum concentration and Area under the serum concentration-time curve from time zero to the time of last quantifiable concentration. Status: unknown.
02
Drugs
LM-001
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03535103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535103.